Ghent University Academic Bibliography

Your filters: cql: author="Curigliano, Giuseppe" or (type any "bookEditor issueEditor" and editor="Curigliano, Giuse...

Add to list
- Journal Article
- A1
- open access
Phase I/IIa trial of BMS-986148, an anti-mesothelin antibody–drug conjugate, alone or in combination with nivolumab in patients with advanced solid tumors

Sylvie Rottey (UGent) , Jeffrey Clarke, Kyaw Aung, Jean-Pascal Machiels, Ben Markman, Kimberley M. Heinhuis, Michael Millward, Martijn Lolkema, Sandip Pravin Patel, Paul de Souza, et al.

(2022) CLINICAL CANCER RESEARCH. 28(1). p.95-105
Add to list
- Journal Article
- A2
- open access
Expected medium- and long-term impact of the COVID-19 outbreak in oncology

Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, Nadia Harbeck, Rupert Bartsch, Hans Wildiers, Vivianne Tjan-Heijnen, Miguel Martin, Sylvie Rottey (UGent) , Daniele Generali, et al.

(2021) JCO GLOBAL ONCOLOGY. 7. p.162-172
Add to list
- Journal Article
- A1
- open access
Anthracyclines strike back : rediscovering non-pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer

Francesco Schettini, Mario Giuliano, Matteo Lambertini, Rupert Bartsch, David James Pinato, Concetta Elisa Onesti, Nadia Harbeck, Diana Lueftner, Sylvie Rottey (UGent) , Peter A. van Dam, et al.

(2021) CANCERS. 13(17).
Add to list
Safety, tolerability, and potential clinical activity of a glucocorticoid-induced TNF receptor-related protein agonist alone or in combination with nivolumab for patients with advanced solid tumors : a phase 1/2a dose-escalation and cohort-expansion clinical trial

Kimberley M Heinhuis, Matteo Carlino, Markus Joerger, Massimo Di Nicola, Tarek Meniawy, Sylvie Rottey (UGent) , Victor Moreno, Anas Gazzah, Jean-Pierre Delord, Luis Paz-Ares, et al.

(2020) JAMA ONCOLOGY. 6(1). p.100-107
Add to list
- Journal Article
- A1
- open access
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Zuzana Kos, Elvire Roblin, Rim S Kim, Stefan Michiels, Brandon D Gallas, Weijie Chen, Koen Van de Vijver (UGent) , Shom Goel, Sylvia Adams, Sandra Demaria, et al.

(2020) NPJ BREAST CANCER. 6(1).
Add to list
Assessing tumor-infiltrating lymphocytes in solid tumors : a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group, part 2 : TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors

Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen Van de Vijver (UGent) , MV Estrada, Paula I Gonzalez-Ericsson, et al.

(2017) ADVANCES IN ANATOMIC PATHOLOGY. 24(6). p.311-335
Add to list
- Journal Article
- A1
- open access
Assessing tumor-infiltrating lymphocytes in solid tumors : a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group, part 1 : assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research

Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen Van de Vijver (UGent) , M.V Estrada, Paula I Gonzalez-Ericsson, et al.

(2017) ADVANCES IN ANATOMIC PATHOLOGY. 24(5). p.235-251

Academic Bibliography

Phase I/IIa trial of BMS-986148, an anti-mesothelin antibody–drug conjugate, alone or in combination with nivolumab in patients with advanced solid tumors

Expected medium- and long-term impact of the COVID-19 outbreak in oncology

Anthracyclines strike back : rediscovering non-pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer

Safety, tolerability, and potential clinical activity of a glucocorticoid-induced TNF receptor-related protein agonist alone or in combination with nivolumab for patients with advanced solid tumors : a phase 1/2a dose-escalation and cohort-expansion clinical trial

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Contents

Support

Contact